IP-strategy for new medical device platform
|Funding from Vinnova||SEK 100 000|
|Project duration||January 2019 - June 2019|
Purpose and goal
The purpose of the project is to develop an IP strategy for the newly developed medical device platform ´Qvicia Platform´. As the platform includes licensing materials, the IP strategy is essential for safe and successful sales and marketing. The objective is to develop an IP strategy including action plan to initiate broader marketing and sales.
Expected results and effects
The goal is to develop an IP strategy including an action plan to safely market and sell material through the platform. IP was early identified as a key issue in order to be able to license material through the platform. As very few similar products have been identified within the MedTech field, benchmarking with regard to IP solutions for similar platforms in other areas has been used. Following the establishment of the IP strategy, the plan is, with the help of consultants, to implement the strategy as soon as possible so that the pilot sales initiated during Q3-Q4 2018 can be increased.
Planned approach and implementation
1) Based on information from companies that have solved similar issues, we are planning to, together with consultants, investigate how identified solutions can be used as a basis for the development of Qvicia´s IP strategy. 2) The plan is to initiate work on IP strategy and the activity plan during Jan-Jun 2019. We will then continue the implementation during Q3-Q4 2019 with the goal of having a sufficiently controllable IP situation in Q4 2019 to be able to focus on broader marketing and sales. 3) Ernst & Young consulting services and dNovo legal (Q1-Q2) in addition to internal work (Q1-Q4).